(ZGNX) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 25, 2013
(Penny Stock DD,
12/3/10)
Mohit Manghnani
Zogenix (ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, priced its IPO on 22nd November, 2010 at $4 per share, with a...(read more)
Zogenix (ZGNX) Company Overview
There is no analysis for ZGNX yet. But you can go to Wikinvest to help create one!
